Summary
Preneoplastic high-risk lesions in the pancreas need to be differentiated from low-risk lesions warranting surveillance and eventually surgical intervention. Imaging is used so far; however, certain imaging features are subject to interpretation and hence have their intrinsic flaws. In a recent article, a liquid biopsy with protein and RNA markers demonstrates differentiation based on a blood test.
This content is only available via PDF.
©2023 American Association for Cancer Research
2023
American Association for Cancer Research
You do not currently have access to this content.